Research from the University of Kent has led to the development of the MeshCODE theory, a revolutionary new theory for understanding brain and memory function. This discovery may be the beginning of a new understanding of brain function and in treating brain diseases such as Alzheimer’s.
Insilico Medicine discovered a completely new drug for pulmonary fibrosis and brought it to the cusp of clinical trials in just 18 months and at a cost of less than $2.7 million, a fraction of what it normally takes.
Some genes don’t stay in the same place in the genome. Sometimes called jumping genes or transposons, this genetic material can hop around and rearrange itself | Genetics And Genomics.
Some genetic sequences don’t stay in the same place in the genome. Sometimes called jumping genes or transposons, this genetic material can hop around and rearrange itself to create new sequences. Some transposons even encode for their own enzymes, and these co-called transposases can edit the genome by cutting sequences from one place and pasting them to another.
Continue reading “New Genes Can Form From ‘Jumping Gene Fusions” »
Some really cool advances happening in cancer detection with things like liquid biopsies from companies like Grail and Thrive:
It’s important to detect cancer early to maximize longevity and survival rates. Here are cancer screening tests for 6 deadly cancers.
Now, Tejada-Martinez and her colleagues have studied the evolution of 1077 tumour suppressor genes (TSGs). In all, they compared the evolution of the genes in 15 mammalian species, including seven cetacean species.
Genes regulating DNA damage, tumour spread and the immune system were positively selected among the cetaceans. The team also found that cetaceans gained and lost TSGs at a rate 2.4 times higher than in other mammals.
It’s not like we’re gonna be taking whale genes and putting them into humans and making humans cancer resistant, says Lynch. But if you can find the genes that play a role in tumour suppression in other animals, and if you could figure out what they’re doing, maybe you can make a drug that mimics that for human treatment…
National Academies study says fusion can help decarbonize US energy, calls for public-private approach to pilot plant operation by 2035–40.
Electricity generated by fusion power plants could play an important role in decarbonizing the U.S. energy sector by mid-century, says a new consensus study report from the National Academies of Sciences, Engineering, and Medicine, which also lays out for the first time a set of technical, economic, and regulatory standards and a timeline for a U.S. fusion pilot plant that would begin producing energy in the 2035–40 time frame.
To achieve this key step toward commercialization, the report calls for an aggressive public-private effort to produce by 2028 a pilot plant design that can, when built, accommodate any of the developmental approaches seeking to realize fusion’s potential as a safe, carbon-free, on-demand energy source.
Curiosity about how well our bodies are ageing has fuelled an industry around telomere length tests, but the much touted “biological clock” in our DNA isn’t what we thought.
A new mathematical algorithm examines data from EEG and brain implants to learn each epilepsy patient’s unique brain pattern signatures. The system can predict the onset of a seizure within an hour, allowing the patient to take necessary interventions.
This list marks 20 years since we began compiling an annual selection of the year’s most important technologies. Some, such as mRNA vaccines, are already changing our lives, while others are still a few years off. Below, you’ll find a brief description along with a link to a feature article that probes each technology in detail. We hope you’ll enjoy and explore—taken together, we believe this list represents a glimpse into our collective future.
Engineers at the University of California San Diego have developed a soft, stretchy skin patch that can be worn on the neck to continuously track blood pressure and heart rate while measuring the wearer’s levels of glucose as well as lactate, alcohol, or caffeine. It is the first wearable device that monitors cardiovascular signals and multiple biochemical levels in the human body at the same time.
“This type of wearable would be very helpful for people with underlying medical conditions to monitor their own health on a regular basis,” said Lu Yin, a nanoengineering Ph.D. student at UC San Diego and co-first author of the study published on February 152021, in Nature Biomedical Engineering. “It would also serve as a great tool for remote patient monitoring, especially during the COVID-19 pandemic when people are minimizing in-person visits to the clinic.”
Such a device could benefit individuals managing high blood pressure and diabetes — individuals who are also at high risk of becoming seriously ill with COVID-19. It could also be used to detect the onset of sepsis, which is characterized by a sudden drop in blood pressure accompanied by a rapid rise in lactate level.
